Skip Navigation LinksHome   |   Reference Center   |   Publication List
  • Print
  • Share

CIBMTR Publication List

Since 1972, use of CIBMTR data and statistical resources have resulted in more than 700 publications in peer-reviewed scientific journals. These publications are organized by year below, and can be searched to help you quickly find the information you need. 

Display:



2014

Year Title Authors Publication
2014 Low CD34 dose is associated with survival after reduced intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome. Törlén J, Ringdén O, Le-Rademacher J, Battiwalla M, Chen J, Erkers T, Ho V, Kebriaei P, Keever-Taylor C, Kindwall-Keller T, Lazarus HM, Laughlin MJ, Lill M, O'Brien T, Perales MA, Rocha V, Savani BN, Szwajcer D, Valcárcel D, Eapen M Biol Blood Marrow Transplant 20(9):1262-1273
2014 Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation. Kim SY, Le-Rademacher J, Antin JH, Anderlini P, Ayas M, Battiwalla M, Carreras J, Kurtzberg J, Nakamura R, Eapen M, Deeg HJ Haematologica
2014 Lenalidomide maintenance for high risk multiple myeloma after allogeneic hematopoietic cell transplantation. Alsina M, Becker PS, Zhong X, Adams A, Hari P, Rowley S, Stadtmauer EA, Vesole DH, Logan B, Weisdorf D, Qazilbash M, Popplewell LL, McClune B, Bensinger W, Riches M, Giralt SA, Pasquini MC Biol Blood Marrow Transplant 20(8):1183-1189
2014 Allogeneic hematopoietic cell transplantation for mycosis fungoides and sezary syndrome. Lechowicz MJ, Lazarus HM, Carreras J, Laport GG, Cutler CS, Wiernik PH, Hale GA, Maharaj D, Gale RP, Rowlings PA, Freytes CO, Miller AM, Vose JM, Maziarz RT, Montoto S, Maloney DG, Hari PN Bone Marrow Transplant
2014 HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. Gragert L, Eapen M, Williams E, Freeman J, Spellman S, Baitty R, Hartzman R, Rizzo JD, Horowitz M, Confer D, Maiers M N Engl J Med 371(4):339-348
2014 Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources. Ballen KK, Joffe S, Brazauskas R, Wang Z, Aljurf MD, Akpek G, Dandoy C, Frangoul HA, Freytes CO, Khera N, Lazarus HM, LeMaistre HM, Mehta P, Parsons SK, Szwajcer D, Ustun C, Wood WA, Majhail NS Biol Blood Marrow Transplant
2014 Older patients with myeloma derive similar benefit from autologous transplantation. Sharma M, Zhang M-J, Zhong X, Abidi MH, Akpek G, Bacher U, Callander NS, Dispenzieri A, Freytes CO, Fung HC, Gale RP, Gasparetto C, Gibson J, Holmberg LA, Kindwall-Keller TL, Klumpp TR, Krishnan AY, Landau HJ, Lazarus HM, Lonial S, Maiolino A, Marks DI, Mehta P, Mikhael JR, Nishihori T, Olsson R, Ramanathan M, Roy V, Savani BN, Schouten HC, Scott E, Tay J, To LB, Vesole DH, Vogl DT, Hari P Biol Blood Marrow Transplant
2014 Second solid cancers after allogeneic hematopoietic cell transplantation using reduced intensity conditioning. Ringdén O, Brazauskas R, Wang Z, Ahmed I, Atsuta Y, Buchbinder B, Burns LJ, Cahn J-Y, Duncan C, Hale GA, Halter J, Hayashi RJ, Hsu JW, Jacobsohn DA, Kamble RT, Kamani NR, Kasow KA, Khera N, Lazarus HM, Loren AW, Marks DI, Myers KC, Ramanathan M, Saber W, Savani B, Schouten HC, Socie G, Sorror ML, Steinberg A, Popat U, Wingard JR, Mattsson J, Majhail NS Biol Blood Marrow Transplant
2014 Acute GVHD: a bench to bedside update. Holtan SG, Pasquini M, Weisdorf DJ Blood 124(3):363-373
2014 Outcomes after hematopoietic stem cell transplant for children with i-cell disease. Lund TC, Cathey SS, Miller WP, Eapen M, Andreansky M, Dvorak CC, Davis JH, Dalal JD, Devine SM, Eames GM, Ferguson WS, Giller RH, He W, Kurtzberg J, Krance R, Katsanis E, Lewis VA, Sahdev I, Orchard PJ Biol Blood Marrow Transplant
2014 Early failure of frontline rituximab-containing chemoimmunotherapy in diffuse large B-cell lymphoma does not predict futility of autologous hematopoietic cell transplantation. Hamadani M, Hari PN, Zhang Y, Carreras J, Akpek G, Aljurf MD, Ayala E, Bachanova V, Chen AI, Chen Y-B, Costa LJ, Fenske TS, Freytes CO, Ganguly S, Hertzberg MS, Holmberg LA, Inwards DJ, Kamble RT, Kanfer EJ, Lazarus HM, Marks DI, Nishihori T, Olsson R, Reddy NM, Rizzieri DA, Savani BN, Solh M, Vose JM, Wirk B, Maloney DG, Smith SM, Montoto S, Saber W Biol Blood Marrow Transplant
2014 Variation in Medicaid Coverage for Hematopoietic Cell Transplantation. Preussler J, Farnia SH, Denzen EM, Majhail NS J Oncol Pract 10(4):e196-e200
2014 Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival. McClune BL, Ahn KW, Wang H-L, Antin JH, Artz AS, Cahn J-Y, Deol A, Freytes CO, Hamadani M, Holmberg LA, Jagasia MH, Jakubowski AA, Kharfan-Dabaja MA, Lazarus HM, Miller AM, Olsson R, Pedersen TL, Pidala J, Pulsipher MA, Rowe JM, Saber W, van Besien KW, Waller EK, Akpek G, Bacher U, Chao NJ, Chen Y-B, Cooper BW, Dehn J, Aljurf MD, de Lima MJ, Hsu JW, Lewis ID, Marks DI, McGuirk J, Cairo MS, Schouten HC, Szer J, Ramanathan M, Savani BN, Seftel M, Socie G, Vij R, Warlick ED, Weisdorf DJ Biol Blood Marrow Transplant 20(7):960-968
2014 Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission. Holter Chakrabarty JL, Rubinger M, Le-Rademacher J, Wang H-L, Grigg A, Selby GB, Szer J, Rowe JM, Weisdorf DJ, Tallman MS Biol Blood Marrow Transplant 20(7):1021-1025
2014 Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma. Wirk B, Fenske TS, Hamadani M, Zhang M-J, Hu Z-H, Akpek G, Aljurf MD, Armand P, Ayala E, Bachanova V, Bolwell B, Cairo MS, Cashen A, Chen Y-B, Costa LJ, Farhan S, Freytes CO, Gajewski JL, Gibson J, Hale GA, Holmberg LA, Hsu JW, Inwards DJ, Kamble RT, Maharaj D, Maziarz RT, Munker R, Nath R, Reddy NM, Reeder CB, Rizzieri DA, Sauter CS, Savani BN, Schouten HC, Sureda A, Vose JM, Waller EK, Wiernik PH, Gale RP, Burns LJ, Saber W Biol Blood Marrow Transplant 20(7):951-959
2014 Tacrolimus/sirolimus versus tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic hematopoietic cell transplantation. Cutler C, Logan B, Nakamura R, Johnston L, Choi S, Porter D, Hogan WJ, Pasquini M, MacMillan ML, Hsu J, Waller EK, Grupp S, McCarthy P, Wu J, Hu ZH, Carter SL, Horowitz MM, Antin JH Blood
2014 Multi-center biologic assignment trial comparing reduced Intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50-75 with Intermediate-2 and high risk myelodysplastic syndrome Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design and methods. Saber W, Le Rademacher J, Sekeres, Logan B, Lewis M, Mendizabel A, Leifer E, Appelbaum FR, Horowitz MM, Nakamura R, Cutler CS Biol Blood Marrow Transplant
2014 Risk-associations between HLA-DPB1 T cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent from HLA-DPA1. Fleischhauer K, Fernandez-Viña MA, Wang T, Haagenson M, Battiwalla M, Baxter-Lowe LA, Ciceri F, Dehn J, Gajewski J, Hale GA, Heemskerk MBA, Marino SR, McCarthy PL, Miklos D, Oudshoorn M, Pollack MS, Reddy V, Senitzer D, Shaw BE, Waller EK, Lee SJ, Spellman SR Bone Marrow Transplant
2014 Exercise and stress management training prior to hematopoietic cell transplantation: blood and marrow transplant clinical trials network (bmt ctn) 0902. Jacobsen PB, Le-Rademacher J, Jim H, Syrjala K, Wingard JR, Logan B, Wu J, Majhail NS, Wood W, Rizzo JD, Geller NL, Kitko C, Faber E, Abidi MH, Slater S, Horowitz MM, Lee SJ Biol Blood Marrow Transplant
2014 Lower risk of serious adverse events and no increased risk of cancer after PBSC versus bone marrow donation. Pulsipher MA, Chitphakdithai P, Logan BR, Navarro WH, Levine JE, Miller JP, Shaw BE, O'Donnell PV, Majhail NS, Confer DL Blood 123(23):3655-3663
2014 Validation and refinement of the disease risk index for allogeneic stem cell transplantation: a study from the CIBMTR. Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, Rizzo JD, Horowitz MM, Saber W Blood 123(23):3664-3671
2014 A randomized double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (Etanercept) for the treatment of idiopathic pneumonia syndrome following allogeneic stem cell transplantation: Blood and Marrow Transplant Clinical Trials Network. Yanik GA, Horowitz MM, Weisdorf DJ, Logan BR, Ho V, Soiffer RJ, Carter SL, Wu J, Wingard JR, Difronzo NL, Ferrara JL, Giralt S, Madtes DK, Drexler R, White ES, Cooke KR Biol Blood Marrow Transplant 20(6):858-864
2014 Cytotoxic T-Lymphocyte antigen-4 (CTLA-4) single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplant: A Center for International Blood and Marrow Transplant Research Analysis. Sengsayadeth S, Wang T, Lee SJ, Haagenson MD, Spellman S, Fernandez Viña MA, Muller CR, Verneris MR, Savani BN, Jagasia M Biol Blood Marrow Transplant 20(6):900-903
2014 Outcome of transplantation for acute lymphoblastic leukemia in children with down syndrome. Hitzler JK, He W, Doyle J, Cairo M, Camitta BM, Chan KW, Diaz Perez MA, Fraser C, Gross TG, Horan JT, Kennedy-Nasser AA, Kitko C, Kurtzberg J, Lehmann L, O'Brien T, Pulsipher MA, Smith FO, Zhang M-J, Eapen M, Carpenter PA Pediatr Blood Cancer 61(6):1126-1128
2014 Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A Rinsho Ketsueki 55(6):607-632
2014 Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a Center for International Blood and Marrow Transplant Research-Eurocord analysis. Weisdorf D, Eapen M, Ruggeri A, Zhang M-J, Zhong X, Brunstein C, Ustun C, Rocha V, Gluckman E Biol Blood Marrow Transplant 20(6):816-822
2014 Hematopoietic stem cell transplantation in older persons: respecting the heterogeneity of age. Michaelis LC, Hamadani M, Hari PN Expert Rev Hematol 7(3):321-324
2014 Evaluation of peripheral blood stem cell quality in products transported by traditional courier or commercial overnight shipping services. Howard A, Chitphakdithai P, Waller EK, Harris W, Rosenthal H, Nelson W, Majhail N, Navarro W, Walvogel S, Lisy J, Uecker J, Miller J, Spellman SR Transfusion 54(6):1501-1507
2014 Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemia. Wood WA, Lee SJ, Brazauskas R, Wang Z, Aljurf MD, Ballen KK, Buchbinder DK, Dehn J, Freytes CO, Lazarus HM, LeMaistre CF, Mehta P, Szwajcer D, Joffe S, Majhail NS Biol Blood Marrow Transplant 20(6):829-836
2014 Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation. Aplenc R, Zhang M-J, Sung L, Zhu X, Ho V, Cooke K, Dvorak C, Hale G, Isola LM, Lazarus H, McCarthy P, Olsson R, Pulsipher M, Pasquini M, Bunin N Blood 123(22):3504-3511
2014 Outcomes of HLA matched sibling donor hematopoietic cell transplantation in chronic lymphocytic leukemia: myeloablative vs. reduced-intensity conditioning regimens. Sobecks RM, Leis JF, Gale RP, Ahn KW, Zhu X, Sabloff M, de Lima M, Brown JR, Inamoto Y, Hale GA, Aljurf MD, Kamble RT, Hsu JW, Pavletic SZ, Wirk B, Seftel MD, Lewis ID, Alyea EP, Cortes J, Kalaycio ME, Maziarz RT, Saber W Biol Blood Marrow Transplant
2014 Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies. Eapen M, O'Donnell P, Brunstein CG, Wu J, Barowski K, Mendizabal A, Fuchs EJ Biol Blood Marrow Transplant
2014 Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia. Cooley S, Weisdorf DJ, Guethlein LA, Klein JP, Wang T, Marsh SGE, Spellman S, Haagenson MD, Saeturn K, Ladner M, Trachtenberg E, Parham P, Miller JS J Immunol 192(10):4592-4600
2014 CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells from MDS patients against primary MDS and MDSC CD33+ targets. Gleason MK, Ross JA, Warlick ED, Lund TC, Verneris MR, Wiernik A, Spellman S, Haagenson MD, Lenvik AJ, Litzow MR, Epling-Burnette PK, Blazar BR, Weiner LM, Weisdorf DJ, Vallera DA, Miller JS Blood 123(19):3016-3026
2014 Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations. Kuwatsuka Y, Atsuta Y, Horowitz MM, Inagaki J, Kanda J, Kato K, Koh K, Zhang M-J, Eapen M Biol Blood Marrow Transplant 20(5):662-667
2014 Pseudo-value approach for comparing survival medians for dependent data. Ahn KW, Mendolia F Stat Med 33(9):1531-1538
2014 Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts. Aljurf M, Rizzo JD, Mohty M, Hussain F, Madrigal A, Pasquini M, Passweg J, Chaudhri N, Ghavamzadeh A, Solh EH, Atsuta Y, Szer J, Kodera Y, Niederweiser D, Gratwohl A, Horowitz MM Bone Marrow Transplant
2014 Allogeneic hematopoietic cell transplant for acute myeloid leukemia: current state in 2013 and future directions. Kanate AS, Pasquini MC, Hari PN, Hamadani M World J Stem Cells 6(2):69-81
2014 Designing and operationalizing a customized internal evaluation model for cancer treatment support programs. J Cancer Educ
2014 Clinical guide to fertility preservation in hematopoietic cell transplant recipients. Joshi S, Savani BN, Chow EJ, Gilleece MH, Halter J, Jacobsohn DA, Pidala J, Quinn GP, Cahn J-Y, Jakubowski AA, Kamani NR, Lazarus HM, Rizzo JD, Schouten HC, Socie G, Stratton P, Sorror ML, Warwick AB, Wingard JR, Loren AW, Majhail NS Bone Marrow Transplant 49(4):477-484
2014 Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens. Bitan M, He W, Zhang M-J, Abdel-Azim H, Ayas MF, Bielorai B, Carpenter PA, Cairo MS, Diaz MA, Horan JT, Jodele S, Kitko CL, Schultz KR, Kletzel M, Kasow KA, Lehmann LE, Mehta PA, Shah N, Pulsipher MA, Prestidge T, Seber A, Shenoy S, Woolfrey AE, Yu LC, Davies SM Blood 123(10):1615-1620
2014 Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease. Bachanova V, Marks DI, Zhang M-J, Wang H, de Lima M, Aljurf MD, Arellano M, Artz AS, Bacher U, Cahn J-Y, Chen Y-B, Copelan EA, Drobyski WR, Gale RP, Greer JP, Gupta V, Hale GA, Kebriaei P, Lazarus HM, Lewis ID, Lewis VA, Liesveld JL, Litzow MR, Loren AW, Miller AM, Norkin M, Oran B, Pidala J, Rowe JM, Savani BN, Saber W, Vij R, Waller EK, Wiernik PH, Weisdorf DJ Leukemia 28(3):658-665
2014 Second transplants for multiple myeloma relapsing after a previous autotransplant-reduced-intensity allogeneic vs autologous transplantation. Freytes CO, Vesole DH, LeRademacher J, Zhong X, Gale RP, Kyle RA, Reece DE, Gibson J, Schouten HC, McCarthy PL, Lonial S, Krishnan AY, Dispenzieri A, Hari PN Bone Marrow Transplant 49(3):416-421
2014 Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancer. Roth JA, Bensink ME, O'Donnell PV, Fuchs EJ, Eapen M, Ramsey SD J Comp Eff Res 3(2):135-144
2014 Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma. Saad A, Mahindra A, Zhang M-J, Zhong X, Costa LJ, Dispenzieri A, Drobyski WR, Freytes CO, Gale RP, Gasparetto CJ, Holmberg LA, Kamble RT, Krishnan AY, Kyle RA, Marks D, Nishihori T, Pasquini MC, Ramanathan M, Lonial S, Savani BN, Saber W, Sharma M, Sorror ML, Wirk BM, Hari PN Biol Blood Marrow Transplant 20(3):402-408
2014 Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen–identical sibling transplantations for chronic lymphocytic leukemia? Sabloff M, Sobecks RM, Ahn KW, Zhu X, de Lima M, Brown JR, Inamoto Y, Holland HK, Aljurf MD, Laughlin MJ, Kamble RT, Hsu JW, Wirk BM, Seftel M, Lewis ID, Arora M, Alyea EP, Kalaycio ME, Cortes J, Maziarz RT, Gale RP, Saber W Biol Blood Marrow Transplant 20(3):421-424
2014 Treatment of older patients with high-risk myelodysplastic syndromes (MDS): The emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT). Atallah E, Bylow K, Troy J, Saber W Curr Hematol Malig Rep 9(1):57-65
2014 Comparison of statistics in association tests of genetic markers for survival outcomes. Mendolia F, Klein JP, Petersdorf EW, Malkki M, Wang T Stat Med 33(5):828-844
2014 Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. Fernandez-Viña MA, Wang T, Lee SJ, Haagenson M, Aljurf M, Askar M, Battiwalla M, Baxter-Lowe L-A, Gajewski J, Jakubowski AA, Marino S, Oudshoorn M, Marsh SGE, Petersdorf EW, Schultz K, Turner EV, Waller EK, Woolfrey A, Umejiego J, Spellman SR, Setterholm M Blood 123(8):1270-1278
2014 Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors. Marks DI, Woo KA, Zhong X, Appelbaum FR, Bachanova V, Barker JN, Brunstein CG, Gibson J, Kebriaei P, Lazarus HM, Olsson R, Perales M-A, Pidala J, Savani B, Rocha V, Eapen M Haematologica 99(2):322-328
2014 Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation. Kelly MJ, Horan JT, Alonzo TA, Eapen M, Gerbing RB, He W, Lange BJ, Parsons SK, Woods WG Pediatr Blood Cancer 61(2):269-275
2014 Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality. Fenske TS, Zhang M-J, Carreras J, Ayala E, Burns LJ, Cashen A, Costa LJ, Freytes CO, Gale RP, Hamadani M, Holmberg LA, Inwards DJ, Lazarus HM, Maziarz RT, Munker R, Perales M-A, Rizzieri DA, Schouten HC, Smith SM, Waller EK, Wirk BM, Laport GG, Maloney DG, Montoto S, Hari PN J Clin Oncol 32(4):273-281
2014 Blood and Marrow Transplant Clinical Trials Network: progress since the State of the Science Symposium 2007. Ferrara JLM Biol Blood Marrow Transplant 20(2):149-153
2014 Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission. Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, Schouten HC, Lazarus HM, Horwitz EM, Koreth J, Cahn J-Y, Bornhauser M, Seftel M, Cairo MS, Laughlin MJ, Sabloff M, Ringdén O, Gale RP, Kamble RT, Vij R, Gergis U, Mathews V, Saber W, Chen Y-B, Liesveld JL, Cutler CS, Ghobadi A, Uy GL, Eapen M, Weisdorf DJ, Litzow MR Biol Blood Marrow Transplant 20(2):202-208
2014 Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia. Eckrich MJ, Ahn K-W, Champlin RE, Coccia P, Godder K, Horan J, Margolis D, Deeg HJ, Eapen M Am J Hematol 89(2):125-129
2014 Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. Eapen M, Klein JP, Ruggeri A, Spellman S, Lee SJ, Anasetti C, Arcese W, Barker JN, Baxter-Lowe LA, Brown M, Fernandez-Vina MA, Freeman J, He W, Iori AP, Horowitz MM, Locatelli F, Marino S, Maiers M, Michel G, Sanz GF, Gluckman E, Rocha V Blood 123(1):133-140
2014 Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a phase III RCT-BMTCTN protocol 0201. Switzer GE, Bruce JG, Harrington D, Haagenson M, Drexler R, Foley A, Confer D, Bishop M, Anderlini P, Rowley S, Leitman SF, Anasetti C, Wingard JR Biol Blood Marrow Transplant 20(1):118-127
2014 Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the Center for International Blood and Marrow Transplant Research. Gupta V, Malone AK, Hari PN, Ahn KW, Hu Z-H, Gale RP, Ballen KK, Hamadani M, Olavarria E, Gerds AT, Waller EK, Costa LJ, Antin JH, Kamble RT, van Besien KM, Savani BN, Schouten HC, Szer J, Cahn J-Y, de Lima MJ, Wirk B, Aljurf MD, Popat U, Bejanyan N, Litzow MR, Norkin M, Lewis ID, Hale GA, Woolfrey AE, Miller AM, Ustun C, Jagasia MH, Lill M, Maziarz RT, Cortes J, Kalaycio ME, Saber W Biol Blood Marrow Transplant 20(1):89-97
 
 
​​​​​

  Search Publications


View current and planned studies
Last Updated: 7/11/2014 3:27 PM